Atrial natriuretic peptide is involved in renal actions of moxonidine

Hypertension

Volumn 35, Issue 6, 2000, Pages 1215-1220

  Mukaddam Daher, Suhayla ^a   Gutkowska, Jolanta ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Atrial natriuretic factor; Cyclic GMP; Moxonidine; Natriuresis; Receptors, adrenergic, alpha; Receptors, imidazoline

Indexed keywords

ATRIAL NATRIURETIC FACTOR; IMIDAZOLINE I1 RECEPTOR; MOXONIDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; DIURESIS; DRUG EFFECT; DRUG MECHANISM; FEMALE; HYPERTENSION; KALIURESIS; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0034130978     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.6.1215     Document Type: Article

References (36)

1. 1 agents: a new approach to the treatment of hypertension. Ann N Y Acad Sci. 1995;763:642-658.
2. 1: an overview of sympathetic receptors involved in blood pressure control targets for drug treatment J Cardiovasc Pharmacol. 1996;27(suppl 3):S5-S10.
3. Esler M, Kaye D. Increased sympathetic nervous activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure. J Auton Nerv Syst. 1998;72:210-219.
4. Pettinger WA, Umemura S, Smyth DD, Jeffries WB. Renal alpha 2-adrenoceptors and the adenylate cyclase-cAMP system: biochemical and physiological interactions. Am J Physiol. 1987;252:F199-208
5. Baranowska, B, Gutkowska J, Cantin M, Genest J. Plasma immunoreactive atrial natriuretic factor increases markedly after a adrenergic stimulation with clonidine in normally hydrated rats. Biochem Biophys Res Commun. 1987;143:159-163.
6. Baranowska B, Gutkowska J, Talbot P, Genest J, Cantin M. Plasma immunoreactive atrial natriuretic factor is inhibited by selective blockade of alpha 2-adrenergic receptors in conscious Sprague-Dawley rats Neurosci Lett. 1987;76:119-123.
7. Gutkowska J, Mukaddam-Daher S, Tremblay J. The peripheral action of clonidine analog ST-91: involvement of atrial natriuretic factor J Pharmacol Exp Ther. 1997;281:670-676.
8. Mukaddam-Daher S, Coderre C, Gutkowska J. The peripheral actions of clonidine are mediated by atrial natriuretic peptide. Hypertension. 1996; 28:537. Abstract.
9. Chen M, Lee J, Huang BS, Grekin R, Malvin R. Clonidine and morphine increase atrial natriuretic peptide secretion in anesthetized rats Proc Soc Exp Biol Med. 1989;191:299-303.
10. Kobinger W. Central alpha-adrenergic systems as targets for hypotensive drugs. Rev Physiol Biochem Pharmacol. 1987;81:39-100.
11. Laubie M, Schmitt H. Sites of action of clonidine: centrally mediated increase in vagal tone, centrally mediated hypotensive and sympatho-inhibitory effects. Prog Brain Res. 1977;47:337-348.
12. Bousquet P, Feldman J, Schwartz J. Central cardiovascular effects of α-adrenergic drugs: difference between catecholamines and imidazolines J Pharmacol Exp Ther. 1984;230:232-236.
13. Ernsberger P, Giuliano R, Willette RN, Granata AR, Reis DJ. Hypotensive action of clonidine analogues correlates with binding affinity at imidazole and not alpha-2-adrenergic receptors in the rostral ventrolateral medulla. J Hypertens. 1988;6:S554-S557.
14. 1-imidazoline receptors in the rostral ventrolateral medulla. J Cardiovasc Pharmacol 1994;24(suppl I):S1-S8.
15. 1-imidazoline agonist moxonidine decreases sympathetic nerve activity and blood pressure in hypertensives. Hypertension. 1998;32:1022-1027
16. 1 imidazoline receptor agonist, moxonidine Br J Pharmacol 1994;114:1089-1094.
17. Hohage H, Schlatter E, Greven J. Effects of moxonidine and clonidine on renal function and blood pressure in anesthetized rats. Clin Nephrology. 1997;47:316-324.
18. Gutkowska J. Radioimmunoassay for atrial natriuretic factor Nucl Med Biol. 1987;14:323-331.
19. Hamet P, Pang SC, Tremblay J. Atrial natriuretic factor-induced egression of cyclic guanosine 3′:5′-monophosphate in cultured vascular smooth muscle and endothelial cells. J Biol Chem 1989;264: 12364-12369.
20. 1 imidazoline agonist, moxonidine. Br J Pharmacol. 1995;116:2631-2636.
21. Kline RL, Cechetto DF. Renal effects of rilmenidine in anesthetized rats: importance of renal nerves. J Pharmacol Exp Ther. 1993;266: 1556-1562.
22. Greven J, Bronewski-Schwarzer BV. Localization of the diuretic effect of moxonidine in the nephron by micropuncture experiments in anesthetized rats. Ann N Y Acad Sci. 1999;881:383-384.
23. Limon I, Coupry I, Tesson F. Lachaud-Pettiti V, Parini A. Renal imidazoline-guanidinium receptive site: a potential target for antihypertensive drugs. J Cardiovasc Pharmacol. 1992;20:21-23.
24. Emsberger P, Feinland G, Meeley MP, Reis DJ. Characterization and visualization of clonidine-sensitive imidazole sites in rat kidney which recognize clonidine-displacing substance. Am J Hypertens 1990;3: 681-688.
25. Bidet M, Poujeol P, Parini A. Effect of imidazolines on Na transport and intracellular pH in renal proximal tubule cells. Biochem Biophys Acta. 1990;1024:173-178.
26. 1-imidazoline receptor-selective compounds mediate natriuresis in the rat. J Cardiovasc Pharmacol 1995; 26(suppl 2):S63-S67.
27. Bohmann C, Schollmeyer P, Rump LC. Effects of imidazolines on noradrenaline release in rat isolated kidney. Naunyn Schmiedebergs Arch Pharmacol. 1994;349:118-124.
28. Jamison RL, Canaan-Kuhl S, Pratt R. The natriuretic peptides and their receptors. Am J Kidney Dis. 1992;20:519-530.
29. Allan DR, Penner S, Smyth DD. Renal imidazoline preferring sites and solute excretion in the rat. Br J Pharmacol. 1993;108:870-875.
30. Lang C, Choy A-M, Balfour D, Struthers AD. Prazosin attenuates the natriuretic response to atrial natriuretic factor in man. Kidney Int. 1992; 42:433-441.
31. Imaizumi T, Takeshita A. Influence of ANP on sympathetic nerve activity and chronotropic regulation of the heart. J Cardiovasc Electrophysiol. 1993;4:719-729.
32. Lambert C, Ribout C, Robichaud A, Cusson JR. Negative chronotropic effect of the atrial natriuretic peptide in an anesthetized dog model Eur J Pharmacol. 1994;252:245-252.
33. White RE, Lee AB, Shcherbatko AD, Lincoln TM, Schonbrunn A, Armstrong DL. Potassium channel stimulation by natriuretic peptides through cGMP-dependent dephosphorylation. Nature. 1993;361: 263-266.
34. Debinski W, Kuchel O, Buu NT, Cantin M, Genest J. Atrial natriuretic factor partially inhibits the stimulated catecholamine synthesis in superior cervical ganglia of the rat. Neurosci Lett. 1987;77:92-96.
35. Hansson M, Kjorell U, Forsgren S. Increased immunoexpression of atrial natnuretic peptide in the heart conduction system of the rat after cardiac sympathectomy. J Mol Cell Cardiol. 1998;30:2047-2057.
36. Wharton J, Anderson RH, Springall D, Power RF, Rose M, Smith A, Espejo R, Khaghani A, Wallwork J, Yacoub MH, Polak TM. Localisation of atrial natriuretic peptide immunoreactivity in the ventricular myocardium and conduction system of the human fetal and adult heart. Br Heart J. 1988;60:267-274.